Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Capsule preparation containing tegafur, Jimeisita and Potassium Oxonate and preparation method thereof

A technology of potassium oxonate and tegafur, applied in the field of medicine, can solve problems such as instability and poor water solubility, and achieve the effects of stable dissolution rate, fast dissolution rate and improved bioavailability

Active Publication Date: 2009-11-11
LUNAN PHARMA GROUP CORPORATION
View PDF0 Cites 37 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Tegafur is an alkaline drug with poor water solubility and shows instability in acidic solution

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Capsule preparation containing tegafur, Jimeisita and Potassium Oxonate and preparation method thereof
  • Capsule preparation containing tegafur, Jimeisita and Potassium Oxonate and preparation method thereof
  • Capsule preparation containing tegafur, Jimeisita and Potassium Oxonate and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] Embodiment 1 The preparation of this Fategafur, gemesta and oxonate potassium capsule preparations:

[0045] Name of raw material Amount / g

[0046]

[0047] Prescription for tegafur pellets:

[0048] Tegafur 20

[0049] Microcrystalline Cellulose 22

[0050] Appropriate amount of purified water

[0051] Prescription of gemesstat pellets:

[0052] Gimesta 5.25

[0053] starch 10

[0054] Appropriate amount of purified water

[0055] Prescription of gemesstat pellets:

[0056] Potassium oxonate 15..5

[0057] Starch 15

[0058] Appropriate amount of purified water

[0059] other:

[0060] Sodium p-dodecylbenzenesulfonate 10

[0061]

[0062] A total of 1000 capsules were made

[0063] Preparation Process:

[0064] (1) Pass tegafluoride through a 100-mesh sieve, add auxiliary materials and mix evenly, add an appropriate amount of purified water to prepare soft ma...

Embodiment 2

[0067] Embodiment 2 The preparation of this Fategafur, gemesta and oxonate potassium capsule preparations:

[0068] Name of raw material Amount / g

[0069]

[0070] Prescription for tegafur pellets:

[0071] Tegafur 25

[0072] Microcrystalline Cellulose 20

[0073] 2% HPMC aqueous solution appropriate amount

[0074] Prescription of gemesstat pellets:

[0075] Guimesta 7.25

[0076] Microcrystalline Cellulose 12

[0077] 2% HPMC aqueous solution appropriate amount

[0078] Prescription of gemesstat pellets:

[0079] Potassium oxonate 24.5

[0080] Microcrystalline Cellulose 14

[0081] 2% HPMC aqueous solution appropriate amount

[0082] other:

[0083] Sodium Lauryl Sulfate 15

[0084]

[0085] A total of 1000 capsules were made

[0086] Preparation Process:

[0087] (1) Pass tegafur through a 100-mesh sieve, add auxiliary materials and mix evenly, add an approp...

Embodiment 3

[0090] Embodiment 3 The preparation of this Fategafur, gemesta and oxonate potassium capsule preparations:

[0091] Name of raw material Amount / g

[0092]

[0093] Prescription for tegafur pellets:

[0094] Tegafur 25

[0095] Pregelatinized starch 15

[0096] Lactose 12

[0097] 3% HPMC aqueous solution appropriate amount

[0098] Prescription of gemesstat pellets:

[0099] jimmiesta 7

[0100] pregelatinized starch 4

[0101] Lactose 3

[0102] 3% HPMC aqueous solution appropriate amount

[0103] Prescription of Potassium Oxonate Potassium Pellets:

[0104] Potassium oxonate 18

[0105] pregelatinized starch 10

[0106] Lactose 6

[0107] 3% HPMC aqueous solution appropriate amount

[0108] other:

[0109] Sodium Lauryl Sulfate 16

[0110]

[0111] A total of 1000 capsules were made

[0112] The preparation process is the same as in Example 2.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a capsule preparation containing tegafur, Jimeisita and Potassium Oxonate and a preparation method thereof, which is characterized in that the capsule preparation contains tegafu micropill, Jimeisita micropill and Potassium Oxonate micropill, wherein, the micropill is prepared from active drug ingredient, thinner, bond and surface active agent. The micropill is prepared with the extruding-rolling method, the centrifugal-fluidifying method, the pan coating pill floating method and the like, and then, other minor ingredients are added; finally, the capsule is filled. The capsule prepared with the preparation method can be steadily and quickly released in bodies, thus the drug stability is improved. The capsule has high dissolution rate and biological availability, and reduces adverse reaction of medicine.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a pellet capsule preparation containing three kinds of medicines, tegafur, gemesstat and potassium oxonate, and a preparation method thereof. Background technique [0002] Tegafur (FT, FT207) is one of the pyrimidine anticancer drugs. It is the prodrug of 5-fluorouracil (5-FU), and has inhibitory effect on most solid tumors. In the body, it can interfere and block the biosynthesis of DNA, RHA and protein, thereby producing its anticancer effect. Basic medical research and clinical observation have proved that tegafur has less toxic and side effects, higher chemotherapy index, less effect on immunosuppression and related immune organs, and is a safe drug that can be used continuously in clinical practice. This product is absorbed through the gastrointestinal tract after oral administration, and the blood concentration reaches the highest peak within 1-3 hours. The d...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/48A61K31/53A61K47/40A61P35/00A61K31/513A61K31/4412
Inventor 赵志全郝贵周
Owner LUNAN PHARMA GROUP CORPORATION
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com